Symptom improvement in patients treated for recurrent or progressive low-grade glioma

被引:0
|
作者
Dunbar, Erin [1 ]
Kleinberg, Lawrence [1 ]
机构
[1] Johns Hopkins Univ, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:478 / 479
页数:2
相关论文
共 50 条
  • [21] Predictors of Early and Recurrent Seizure in Low-Grade Glioma
    Jo, Jasmin
    Nevel, Kathryn
    Sutyla, Ryan
    Smolkin, Mark
    Lopes, M. Beatriz
    Schiff, David
    NEUROLOGY, 2018, 90
  • [22] Phase II Trial of Oral Vinorelbine in Children with Progressive or Recurrent Unresectable Low-Grade Glioma
    Leblond, P.
    Bimbai, A. -M.
    Probst, A.
    Chastagner, P.
    DeCarli, E.
    Pagnier, A.
    Grill, J.
    Entz-Werle, N.
    Bourdeaut, F.
    Faure-Conter, C.
    Bertozzi, A. -I.
    Boulanger, T.
    Caron, S.
    Le Deley, M. -C.
    Andre, N.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S82 - S83
  • [23] Phase II trial of imatinib mesylate and hydroxyurea for adults with recurrent/progressive low-grade glioma
    Bota, D. A.
    Desjardins, A.
    Quinn, J. A.
    Rich, J. N.
    Vredenburgh, J. J.
    Sathornsumetee, S.
    Goli, K.
    Salvado, A.
    Friedman, H. S.
    Reardon, D. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [24] Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma
    Reardon, David A.
    Desjardins, Annick
    Vredenburgh, James J.
    Herndon, James E., II
    Coan, April
    Gururangan, Sridharan
    Peters, Katherine B.
    McLendon, Roger
    Sathornsumetee, Sith
    Rich, Jeremy N.
    Lipp, Eric S.
    Janney, Dorothea
    Friedman, Henry S.
    CANCER, 2012, 118 (19) : 4759 - 4767
  • [25] PHASE I TRIAL OF DAY101 IN PEDIATRIC PATIENTS WITH RADIOGRAPHICALLY RECURRENT OR PROGRESSIVE LOW-GRADE GLIOMA (LGG)
    Wright, Karen
    Krzykwa, Emily
    Greenspan, Lianne
    Chi, Susan
    Yeo, Kee Kiat
    Prados, Michael
    Mueller, Sabine
    Haas-Kogan, Daphne
    NEURO-ONCOLOGY, 2020, 22 : 46 - 46
  • [26] Vinorelbine in progressive unresectable low-grade glioma in children.
    Cappellano, A. M.
    Bouffet, E.
    Silva, F.
    Paiva, P.
    Alves, M. T. d. S.
    Cavalheiro, S.
    Silva, N. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [27] Low-grade glioma
    Sampson, John H.
    JOURNAL OF NEUROSURGERY, 2011, 114 (03) : 563 - 564
  • [28] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Koekkoek, Johan A. F.
    Dirven, Linda
    Heimans, Jan J.
    Postma, Tjeerd J.
    Vos, Maaike J.
    Reijneveld, Jaap C.
    Taphoorn, Martin J. B.
    JOURNAL OF NEURO-ONCOLOGY, 2016, 126 (02) : 347 - 354
  • [29] Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide
    Johan A. F. Koekkoek
    Linda Dirven
    Jan J. Heimans
    Tjeerd J. Postma
    Maaike J. Vos
    Jaap C. Reijneveld
    Martin J. B. Taphoorn
    Journal of Neuro-Oncology, 2016, 126 : 347 - 354
  • [30] SINGLE AGENT VINORELBINE IN PEDIATRIC AND ADOLESCENT PATIENTS WITH PROGRESSIVE UNRESECTABLE LOW-GRADE GLIOMA
    Cappellano, A.
    Bouffet, E.
    Silva, F. A.
    Cavalheiro, S.
    Alves, M. T. S.
    Toledo, S.
    Dias, I.
    da Silva, N. S.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S273 - S273